Skip to main content
. 2015 Mar;15(1):253–260. doi: 10.4314/ahs.v15i1.33

Table 2.

Determinants of changes in hematologic parameters during follow-up, based on mixed linear regression models

Variable Hemoglobin (g/dl) Mean corpuscular Mean corpuscular
volume (fl) hemoglobin (pg)
Intercept 9.4 (8.4 to 10.5) 83.6 (78.7 to 88.6) 26.9 (25.2 to 28.5)
Men vs. women 0.1 (−0.2 to 0.5) −1.3 (−2.9 to 0.3) −0.2 (−0.7 to 0.4)
Age (per 10 years) 0.07 (−0.04 to 0.2) 0.9 (0.4 to 1.5) 0.3 (0.2 to 0.5)
Duration in dialysis (per 10 months) 0.3 (0.2 to 0.4) −0.4 (−0.9 to 0.1) −0.2 (−2.5 to 1.4)
No diabetes vs. diabetes −0.01 (−0.4 to 0.4) 2.4 (0.6 to 4.2) 0.8 (0.2 to 1.5)
No HIV vs. HIV infection 0.04 (−0.6 to 0.7) −.3 (−3.3 to 2.8) −.1 (−1.6 to 0.9)
No iron vs. iron therapy −0.5 (−0.9 to −0.1) −1.7 (−3.5 to 0.2) −0.4 (−1.1 to 0.2)
No EPO vs. EPO therapy −1.1 (−1.6 to −0.6) −2.6 (−4.9 to −0.4) −0.9 (−1.6 to −0.1)
Blood transfusion (per pint) −0.7 (−0.9 to −0.6) −0.1 (−0.7 to 0.5) −0.1 (−0.2 to 0.1)

EPO - Erythropoietin; HIV - Human Immunodeficiency Virus.